ESSENTIAL Trial™ Sham Cross-over

NACompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

January 5, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

September 30, 2016

Conditions
Obesity
Interventions
DEVICE

g-Cath EZ™ Suture Anchor Delivery Catheter

This is a multicenter, un-blinded, open label, pivotal supplemental study to G130163 intended to evaluate the safety and efficacy of treating previous sham subjects in the Essential pivotal trial (IDE#G130163) with the active treatment (the placement of g-Cath EZ suture anchors along with diet and exercise). Compliant sham subjects (those who attended all primary IDE follow-up visits AND who continue to meet eligibility criteria as described in this protocol) will be offered this active treatment after their 12 month unblinding visit in the Essential pivotal trial.

Trial Locations (11)

29169

Lexington Medical Center, West Columbia

30720

Hamilton Medical Center, Dalton

33166

University of Miami Hospital, Miami

38120

Baptist Memorial Hospital, Memphis

55455

Fairview UMMC-University, Minneapolis

60201

Northshore/Evanston Hospital, Evanston

63110

WA University School of Medicine, St Louis

64111

Saint Luke's Hospital, Kansas City

70001

Crescent City Surgical, Metairie

85258

Shea Campus -Scottsdale Healthcare, Scottsdale

02115

Brigham & Women's Hospital, Boston

All Listed Sponsors
lead

USGI Medical

INDUSTRY

NCT02279420 - ESSENTIAL Trial™ Sham Cross-over | Biotech Hunter | Biotech Hunter